Eric Easom
Fondateur chez AN2 THERAPEUTICS, INC.
Fortune : 3 M $ au 30/04/2024
Postes actifs de Eric Easom
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| AN2 THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/11/2019 | - |
| Directeur Général | 01/11/2019 | - | |
| Fondateur | 01/02/2017 | - | |
| President | 01/11/2019 | - | |
| Chagas Disease Foundation | Directeur/Membre du Conseil | 01/06/2018 | - |
Resilient Biotics, Inc.
 Resilient Biotics, Inc. Miscellaneous Commercial ServicesCommercial Services Resilient Biotics, Inc. designs microbiome-based therapeutics and screening methods. The firm offers prevention and precision treatment for deadly infectious diseases. The company was founded by Christopher P. Belnap and is headquartered in El Cerrito, CA. | Directeur/Membre du Conseil | 01/02/2019 | - |
Historique de carrière de Eric Easom
Anciens postes connus de Eric Easom
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ANACOR PHARMACEUTICALS INC | Corporate Officer/Principal | 01/02/2009 | 01/06/2017 |
Infectious Disease Research Institute
 Infectious Disease Research Institute Miscellaneous Commercial ServicesCommercial Services Infectious Disease Research Institute operates as a innovative science to research and development company. It offers pipeline, adjuvants, vaccines, diagnostics and drugs products. The firm also provides manufacturing, analytical methods, stability studies, process and contact services. The company was founded by Steven G. Reed in 1993 and is headquartered in Seattle, WA. | Directeur/Membre du Conseil | 01/01/2013 | 01/01/2014 |
| Président | 01/01/2009 | 01/01/2013 | |
InteKrin Therapeutics, Inc.
 InteKrin Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology InteKrin Therapeutics, Inc. develops and commercializes therapeutics for metabolic and immune disorders. It develops therapeutics for diabetes, insulin resistance and multiple sclerosis. The company was founded by Dennis M. Lanfear and Christos S. Mantzoros in 2005 and is headquartered in Palo Alto, CA. | Sales & Marketing | 01/07/2007 | 01/01/2009 |
| Medimmune, Inc. | Sales & Marketing | 01/04/2006 | 01/07/2007 |
Formation de Eric Easom
| Kelley School of Business | Masters Business Admin |
| University of Louisville | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 10 |
Opérationnelle
| Director/Board Member | 4 |
| Sales & Marketing | 2 |
| Chief Executive Officer | 1 |
Sectorielle
| Health Technology | 5 |
| Commercial Services | 3 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| AN2 THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 6 |
|---|---|
| Chagas Disease Foundation | |
Resilient Biotics, Inc.
Resilient Biotics, Inc. Miscellaneous Commercial ServicesCommercial Services Resilient Biotics, Inc. designs microbiome-based therapeutics and screening methods. The firm offers prevention and precision treatment for deadly infectious diseases. The company was founded by Christopher P. Belnap and is headquartered in El Cerrito, CA. | Commercial Services |
Infectious Disease Research Institute
Infectious Disease Research Institute Miscellaneous Commercial ServicesCommercial Services Infectious Disease Research Institute operates as a innovative science to research and development company. It offers pipeline, adjuvants, vaccines, diagnostics and drugs products. The firm also provides manufacturing, analytical methods, stability studies, process and contact services. The company was founded by Steven G. Reed in 1993 and is headquartered in Seattle, WA. | Commercial Services |
Anacor Pharmaceuticals LLC
 Anacor Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Anacor Pharmaceuticals, Inc. develops medical solutions. The firm operates as a biopharmaceutical company, which focuses on discovering, developing, and commercializing novel small-molecule therapeutics derived from its boron chemistry platform. The company was founded by Lucy Shapiro, Stephen J. Benkovic, and David P. Perry in 2000 and is headquartered in Palo Alto, CA. | Health Technology |
InteKrin Therapeutics, Inc.
InteKrin Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology InteKrin Therapeutics, Inc. develops and commercializes therapeutics for metabolic and immune disorders. It develops therapeutics for diabetes, insulin resistance and multiple sclerosis. The company was founded by Dennis M. Lanfear and Christos S. Mantzoros in 2005 and is headquartered in Palo Alto, CA. | Health Technology |
| Medimmune, Inc. | Health Technology |
- Bourse
- Insiders
- Eric Easom
- Expérience